These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 4007891)

  • 1. A study of the effects of rifampicin on isoniazid metabolism in human volunteer subjects.
    Timbrell JA; Park BK; Harland SJ
    Hum Toxicol; 1985 May; 4(3):279-85. PubMed ID: 4007891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absence of CYP3A genetic polymorphism assessed by urinary excretion of 6 beta-hydroxycortisol in 102 healthy subjects on rifampicin.
    Horsmans Y; Desager JP; Harvengt C
    Pharmacol Toxicol; 1992 Oct; 71(4):258-61. PubMed ID: 1454750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isoniazid-related hepatotoxicity: a study of the effect of rifampicin administration on the metabolism of acetylisoniazid in man.
    Jenner PJ; Ellard GA
    Tubercle; 1989 Jun; 70(2):93-101. PubMed ID: 2617692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of urinary 6-beta-hydroxycortisol excretion as an in vivo parameter in the clinical assessment of the microsomal enzyme-inducing capacity of antipyrine, phenobarbitone and rifampicin.
    Ohnhaus EE; Park BK
    Eur J Clin Pharmacol; 1979 Mar; 15(2):139-45. PubMed ID: 35353
    [No Abstract]   [Full Text] [Related]  

  • 5. [The influence of rifampicin upon the metabolism of isoniazid (author's transl)].
    Modai J; Coulaud JP; Vivien JM; Berthelot G; Bergogne-Berezin E
    Nouv Presse Med; 1978 Apr; 7(15):1263-7. PubMed ID: 662655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the effects of isoniazid on acetylhydrazine metabolism in vivo and in vitro.
    Timbrell JA; Wright JM
    Drug Metab Dispos; 1979; 7(4):237-40. PubMed ID: 39727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of rifampicin and phenobarbital on the fate of isoniazid and hydrazine in vivo in rats.
    Noda A; Sendo T; Ohno K; Goto S; Noda H; Hsu KY
    Toxicol Lett; 1985 Jun; 25(3):313-7. PubMed ID: 4012807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rifampin-induced release of hydrazine from isoniazid. A possible cause of hepatitis during treatment of tuberculosis with regimens containing isoniazid and rifampin.
    Sarma GR; Immanuel C; Kailasam S; Narayana AS; Venkatesan P
    Am Rev Respir Dis; 1986 Jun; 133(6):1072-5. PubMed ID: 3717759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoacetylhydrazine as a metabolite of isoniazid in man.
    Timbrell JA; Wright JM; Baillie TA
    Clin Pharmacol Ther; 1977 Nov; 22(5 Pt 1):602-8. PubMed ID: 913027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary excretion of 6 beta-hydroxycortisol as an in vivo marker for CYP3A induction: applications and recommendations.
    Kovacs SJ; Martin DE; Everitt DE; Patterson SD; Jorkasky DK
    Clin Pharmacol Ther; 1998 Jun; 63(6):617-22. PubMed ID: 9663175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Simultaneous study of the induction effect of rifampicin and the phenotype for acetylation of isoniazid in 21 patients with tuberculosis undergoing a combination treatment].
    Chailleux E; Ordronneau J; Le Normand Y; Kergueris MF; Larousse C
    Rev Fr Mal Respir; 1980; 8(3):219-24. PubMed ID: 7187065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antibacterian activity modifications of serum isoniazid when using it with rifampicin (author's transl)].
    Nouhouayi A; Bergogne-Berezin E; Lafaix C
    Pathol Biol (Paris); 1982 Jun; 30(6):389-93. PubMed ID: 7050848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzyme-inducing drug combinations and their effects on liver microsomal enzyme activity in man.
    Ohnhaus EE; Gerber-Taras E; Park BK
    Eur J Clin Pharmacol; 1983; 24(2):247-50. PubMed ID: 6840175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The increase in urinary excretion of 6 beta-hydroxycortisol as a marker of human hepatic cytochrome P450IIIA induction.
    Ged C; Rouillon JM; Pichard L; Combalbert J; Bressot N; Bories P; Michel H; Beaune P; Maurel P
    Br J Clin Pharmacol; 1989 Oct; 28(4):373-87. PubMed ID: 2590599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic mixed function oxidase induction during rifampicin/isoniazid therapy in Indian vegetarians.
    Perry W; Jenkins MV
    Int J Clin Pharmacol Ther Toxicol; 1986 Jul; 24(7):344-8. PubMed ID: 3733284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is isoniazid-hepatotoxicity induced by the metabolite, hydrazine?
    Noda A; Hsu KY; Noda H; Yamamoto Y; Kurozumi T
    J UOEH; 1983 Jun; 5(2):183-90. PubMed ID: 6679629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of rifampicin and isoniazid on the kinetics of phenytoin.
    Kay L; Kampmann JP; Svendsen TL; Vergman B; Hansen JE; Skovsted L; Kristensen M
    Br J Clin Pharmacol; 1985 Oct; 20(4):323-6. PubMed ID: 4074601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effects of rifabutin and rifampicin on hepatic microsomal enzyme activity in normal subjects.
    Perucca E; Grimaldi R; Frigo GM; Sardi A; Mönig H; Ohnhaus EE
    Eur J Clin Pharmacol; 1988; 34(6):595-9. PubMed ID: 2901960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Biotransformation of rifampicin in pulmonary tuberculosis patients].
    Ioffe RA
    Antibiotiki; 1977; 22(2):177-80. PubMed ID: 558736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of prednisolone and rifampin on isoniazid metabolism in slow and rapid inactivators of isoniazid.
    Sarma GR; Kailasam S; Nair NG; Narayana AS; Tripathy SP
    Antimicrob Agents Chemother; 1980 Nov; 18(5):661-6. PubMed ID: 7447424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.